Ulises Nobo, MD
Neurology · Caguas, PRNPI 1487705141
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.9% of the total across 38 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by Medtronic at 42.6% of the total. Reporting peaked in 2024 at $762 and has fallen 53.4% since, to $355 in 2025.
Across 38 payments — averaging $64.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$1K
- Abbott$441
- Johnson & Johnson$345
- Boston Scientific$222
- E.r. Squibb & Sons, L.L.C.$137
- Penumbra, Inc.$84
- plus $172 from 4 others
What the payments were for
- Food & beverage$2,39098%
- Gifts$502%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 11 | $1,039 |
| Abbott | 6 | $441 |
| Johnson & Johnson | 6 | $345 |
| Boston Scientific | 3 | $222 |
| E.r. Squibb & Sons, L.L.C. | 2 | $137 |
| Penumbra, Inc. | 2 | $84 |
| PBG Puerto Rico LLC | 2 | $53 |
| Genentech USA, Inc. | 4 | $53 |
| Chiesi USA, Inc. | 1 | $50 |
| AstraZeneca | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LINQ II$542
- WATCHMAN FLX$138
- ELIQUIS$125
- JOT DX$121
- Confirm Rx$118
- Pipeline$118
- Reveal LINQ$110
- VANTAGE ANTERIOR FIXATION SYSTEM$105
How this compares
$2,441 in reported general payments places this provider in the 60th percentile of 129 neurology providers in Puerto Rico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 20 | $139 |
| Quetiapine Fumarate | 15 | $107 |
| Escitalopram Oxalate | 11 | $36 |
| Donepezil Hcl | 11 | $31 |
Paid to pharmacies, not to this prescriber.
Other neurology in Caguas
- Jose Avila OrnelasCaguas$538K
- Patricia de JesusCaguas$310K
- Karen Nater PineiroCaguas$7K
- Luis ForastieriCaguas$6K
- Naggai Gonzalez SegarraCaguas$4K
- Daniel Reyes de JesusCaguas$3K
- Angel ChineaGuaynabo$1.7M
- Franchesca Fiorito-TorresSan Juan$453K
- Mari GarciaSan Juan$138K
- Cristina Cabret-AymatSan Juan$108K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.